• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

xCT(SLC7A11)介导的代谢重编程促进非小细胞肺癌的进展。

xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression.

机构信息

Cancer Early Detection and Prevention Initiative, Vanderbilt Ingram Cancer Center, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, 37232, USA.

Department of Nutrition, Byrdine F. Lewis School of Nursing and Health Professions, Georgia State University, Atlanta, 30302, USA.

出版信息

Oncogene. 2018 Sep;37(36):5007-5019. doi: 10.1038/s41388-018-0307-z. Epub 2018 May 23.

DOI:10.1038/s41388-018-0307-z
PMID:29789716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6127081/
Abstract

Many tumors increase uptake and dependence on glucose, cystine or glutamine. These basic observations on cancer cell metabolism have opened multiple new diagnostic and therapeutic avenues in cancer research. Recent studies demonstrated that smoking could induce the expression of xCT (SLC7A11) in oral cancer cells, suggesting that overexpression of xCT may support lung tumor progression. We hypothesized that overexpression of xCT occurs in lung cancer cells to satisfy the metabolic requirements for growth and survival. Our results demonstrated that 1) xCT was highly expressed at the cytoplasmic membrane in non-small cell lung cancer (NSCLC), 2) the expression of xCT was correlated with advanced stage and predicted a worse 5-year survival, 3) targeting xCT transport activity in xCT overexpressing NSCLC cells with sulfasalazine decreased cell proliferation and invasion in vitro and in vivo and 4) increased dependence on glutamine was observed in xCT overexpressed normal airway epithelial cells. These results suggested that xCT regulate metabolic requirements during lung cancer progression and be a potential therapeutic target in NSCLC.

摘要

许多肿瘤增加了对葡萄糖、胱氨酸或谷氨酰胺的摄取和依赖。这些关于癌细胞代谢的基本观察结果为癌症研究开辟了多个新的诊断和治疗途径。最近的研究表明,吸烟可以诱导口腔癌细胞中 xCT(SLC7A11)的表达,这表明 xCT 的过表达可能支持肺癌的进展。我们假设 xCT 在肺癌细胞中的过表达是为了满足生长和存活的代谢需求。我们的研究结果表明:1)xCT 在非小细胞肺癌(NSCLC)的细胞质膜中高度表达;2)xCT 的表达与晚期阶段相关,并预测 5 年生存率较差;3)用柳氮磺胺吡啶靶向 xCT 过表达 NSCLC 细胞中的 xCT 转运活性,可降低体外和体内的细胞增殖和侵袭;4)在 xCT 过表达的正常气道上皮细胞中观察到对谷氨酰胺的依赖性增加。这些结果表明,xCT 调节肺癌进展过程中的代谢需求,可能成为 NSCLC 的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba40/6127081/1e243a197a19/41388_2018_307_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba40/6127081/4e18c6adcea0/41388_2018_307_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba40/6127081/3695ed464a17/41388_2018_307_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba40/6127081/1e243a197a19/41388_2018_307_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba40/6127081/4e18c6adcea0/41388_2018_307_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba40/6127081/3695ed464a17/41388_2018_307_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba40/6127081/1e243a197a19/41388_2018_307_Fig5_HTML.jpg

相似文献

1
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression.xCT(SLC7A11)介导的代谢重编程促进非小细胞肺癌的进展。
Oncogene. 2018 Sep;37(36):5007-5019. doi: 10.1038/s41388-018-0307-z. Epub 2018 May 23.
2
Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy.胱氨酸转运蛋白 SLC7A11/xCT 在癌症中的作用:铁死亡、营养依赖性和癌症治疗。
Protein Cell. 2021 Aug;12(8):599-620. doi: 10.1007/s13238-020-00789-5. Epub 2020 Oct 1.
3
The glutamate/cystine antiporter SLC7A11/xCT enhances cancer cell dependency on glucose by exporting glutamate.谷氨酸/胱氨酸反向转运体SLC7A11/xCT通过输出谷氨酸增强癌细胞对葡萄糖的依赖性。
J Biol Chem. 2017 Aug 25;292(34):14240-14249. doi: 10.1074/jbc.M117.798405. Epub 2017 Jun 19.
4
Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.谷氨酰胺分解相关基因决定了头颈部鳞状细胞癌对 xCT 靶向治疗的敏感性。
Cancer Sci. 2019 Nov;110(11):3453-3463. doi: 10.1111/cas.14182. Epub 2019 Sep 13.
5
Kinetic analysis of cystine uptake and inhibition pattern of sulfasalazine in A549 cells.半胱氨酸摄取的动力学分析及柳氮磺胺吡啶在 A549 细胞中的抑制模式。
Biopharm Drug Dispos. 2021 Sep;42(8):389-392. doi: 10.1002/bdd.2298. Epub 2021 Jul 29.
6
Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury.胱氨酸/谷氨酸反向转运蛋白(xCT)是胃损伤后主细胞可塑性所必需的。
Cell Mol Gastroenterol Hepatol. 2019;8(3):379-405. doi: 10.1016/j.jcmgh.2019.04.015. Epub 2019 May 6.
7
Redox-dependent AMPK inactivation disrupts metabolic adaptation to glucose starvation in xCT-overexpressing cancer cells.氧化还原依赖的 AMPK 失活破坏了 xCT 过表达癌细胞对葡萄糖饥饿的代谢适应。
J Cell Sci. 2022 Aug 1;135(15). doi: 10.1242/jcs.259090. Epub 2022 Aug 10.
8
The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility.谷氨酸/胱氨酸 xCT 载体拮抗谷氨酰胺代谢,降低营养灵活性。
Nat Commun. 2017 Apr 21;8:15074. doi: 10.1038/ncomms15074.
9
Amino acid transporter SLC7A11/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer.氨基酸转运蛋白 SLC7A11/xCT 在调节氧化还原平衡和肿瘤营养依赖性的十字路口。
Cancer Commun (Lond). 2018 Apr 25;38(1):12. doi: 10.1186/s40880-018-0288-x.
10
High cell density increases glioblastoma cell viability under glucose deprivation via degradation of the cystine/glutamate transporter xCT (SLC7A11).高细胞密度通过降解胱氨酸/谷氨酸转运体 xCT(SLC7A11)增加葡萄糖剥夺条件下胶质母细胞瘤细胞的活力。
J Biol Chem. 2020 May 15;295(20):6936-6945. doi: 10.1074/jbc.RA119.012213. Epub 2020 Apr 7.

引用本文的文献

1
tRNA-derived small RNAs: emerging regulators of ferroptosis in human diseases.转运RNA衍生的小RNA:人类疾病中铁死亡的新兴调节因子
Hum Cell. 2025 Sep 17;38(6):162. doi: 10.1007/s13577-025-01293-w.
2
Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming in EGFR-Mutant Lung Cancer.表皮生长因子受体(EGFR)突变型肺癌中的细胞死亡、分子靶向治疗与代谢重编程
Cancers (Basel). 2025 Aug 27;17(17):2791. doi: 10.3390/cancers17172791.
3
Impaired xCT-mediated cystine uptake drives serine and proline metabolic reprogramming and mitochondrial fission in skeletal muscle cells.

本文引用的文献

1
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma.线粒体调节异常和糖酵解功能不全在功能上损害浸润人肾细胞癌的CD8 T细胞。
JCI Insight. 2017 Jun 15;2(12). doi: 10.1172/jci.insight.93411.
2
SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma.溶质载体家族7成员11(SLC7A11)的表达与癫痫发作相关,并预示恶性胶质瘤患者的预后不良。
Sci Transl Med. 2015 May 27;7(289):289ra86. doi: 10.1126/scitranslmed.aaa8103.
3
MYC oncogene overexpression drives renal cell carcinoma in a mouse model through glutamine metabolism.
xCT介导的胱氨酸摄取受损驱动骨骼肌细胞中的丝氨酸和脯氨酸代谢重编程以及线粒体裂变。
Redox Biol. 2025 Aug 21;86:103839. doi: 10.1016/j.redox.2025.103839.
4
Clinical and biological impact of SNAT7 in lung adenocarcinoma: implications for prognosis and treatment.溶质载体家族7成员7(SNAT7)在肺腺癌中的临床和生物学影响:对预后和治疗的意义
Int J Clin Oncol. 2025 Aug 12. doi: 10.1007/s10147-025-02851-w.
5
Downregulation of NCOA4 expression indicates poor prognosis and promotes the progression of cholangiocarcinoma.NCOA4表达下调提示预后不良并促进胆管癌进展。
PLoS One. 2025 Aug 11;20(8):e0327722. doi: 10.1371/journal.pone.0327722. eCollection 2025.
6
Repurposing Asparaginase Therapy to Target Cisplatin-Resistant Cancer Cells.重新利用天冬酰胺酶疗法靶向顺铂耐药癌细胞。
Fundam Clin Pharmacol. 2025 Oct;39(5):e70044. doi: 10.1111/fcp.70044.
7
"Molecular pigeon" network of lncRNA and miRNA: decoding metabolic reprogramming in patients with lung cancer.lncRNA与miRNA的“分子信鸽”网络:解读肺癌患者的代谢重编程
Front Oncol. 2025 Jul 17;15:1578927. doi: 10.3389/fonc.2025.1578927. eCollection 2025.
8
The role of the NcRNA/ferroptosis axis in lung cancer: molecular mechanisms and potential therapeutic targets.非编码RNA/铁死亡轴在肺癌中的作用:分子机制与潜在治疗靶点
Apoptosis. 2025 Jun 22. doi: 10.1007/s10495-025-02127-8.
9
p53-mediated suppression of the SLC7 A11/GPX4 signaling pathway promotes trophoblast ferroptosis in preeclampsia.p53介导的SLC7A11/GPX4信号通路抑制促进子痫前期中滋养层细胞铁死亡。
BMC Biol. 2025 May 28;23(1):141. doi: 10.1186/s12915-025-02240-9.
10
Sulfasalazine combined with anti-IL-1β mAb induces ferroptosis and immune modulation in oral squamous cell carcinoma.柳氮磺胺吡啶联合抗IL-1β单克隆抗体可诱导口腔鳞状细胞癌发生铁死亡并调节免疫。
Cell Mol Life Sci. 2025 May 28;82(1):216. doi: 10.1007/s00018-025-05742-5.
MYC癌基因的过表达通过谷氨酰胺代谢在小鼠模型中驱动肾细胞癌。
Proc Natl Acad Sci U S A. 2015 May 26;112(21):6539-44. doi: 10.1073/pnas.1507228112. Epub 2015 May 11.
4
The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers.RNA结合蛋白FXR1是3q26 - 29扩增子中的一个新驱动因子,并预示人类癌症预后不良。
Proc Natl Acad Sci U S A. 2015 Mar 17;112(11):3469-74. doi: 10.1073/pnas.1421975112. Epub 2015 Mar 2.
5
Nrf2- and ATF4-dependent upregulation of xCT modulates the sensitivity of T24 bladder carcinoma cells to proteasome inhibition.Nrf2 和 ATF4 依赖性上调 xCT 调节 T24 膀胱癌细胞对蛋白酶体抑制的敏感性。
Mol Cell Biol. 2014 Sep 15;34(18):3421-34. doi: 10.1128/MCB.00221-14. Epub 2014 Jul 7.
6
Modulation of oxidative stress as an anticancer strategy.氧化应激调节作为一种抗癌策略。
Nat Rev Drug Discov. 2013 Dec;12(12):931-47. doi: 10.1038/nrd4002.
7
Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target.谷氨酰胺敏感性分析确定 xCT 外排体为常见的三阴性乳腺癌治疗靶点。
Cancer Cell. 2013 Oct 14;24(4):450-65. doi: 10.1016/j.ccr.2013.08.020. Epub 2013 Oct 3.
8
ETA: robust software for determination of cell specific rates from extracellular time courses.ETA:用于从细胞外时间过程中确定细胞特异性速率的强大软件。
Biotechnol Bioeng. 2013 Jun;110(6):1748-58. doi: 10.1002/bit.24836. Epub 2013 Jan 21.
9
SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival.SLC1A5 介导肺癌细胞生长和存活所需的谷氨酰胺转运。
Clin Cancer Res. 2013 Feb 1;19(3):560-70. doi: 10.1158/1078-0432.CCR-12-2334. Epub 2012 Dec 4.
10
Enhanced expression of cystine/glutamate transporter in the lung caused by the oxidative-stress-inducing agent paraquat.百草枯这种氧化应激诱导剂会导致肺部胱氨酸/谷氨酸转运体表达增强。
Free Radic Biol Med. 2012 Dec 15;53(12):2197-203. doi: 10.1016/j.freeradbiomed.2012.09.040. Epub 2012 Oct 17.